Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Two Telaprevir Dose Regimens with Peginterferon alfa-2a and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C
2007-004720-20Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of telaprevir in chronic hepatitis C virus infection (2 arms), sponsored by Vertex Pharmaceuticals. Started Feb 2008; status: completed.
02
Drugs
telaprevir
03
Conditions
chronic hepatitis C virus infection
Beyond the preview
Go deeper on 2007-004720-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004720-20.